CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Shiru is inviting partners to harness its AI-powered ingredient discovery platform to explore ingredients that naturally ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA ...

2025 NBA Mock Draft: Kevin Durant trade shakes up first round, leaves Suns with complicated decision at No. 10 Tech investor ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.